Phio Pharmaceuticals Corp. (PHIO) financial statements and ratios from SEC XBRL: revenue $0.00 (TTM). Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $0.00 |
| Price / Book | 1.09 |
| FCF Yield | -160.2% |
| Sector P/E (Healthcare) | 21.7 |
PHIO overview · PHIO earnings · PHIO KPIs · PHIO investor relations · PHIO ownership · PHIO peers · PHIO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.